Latest Regulatory News

BlackRock Investment Management (Australia) Limited has updated its estimated cash distributions for the iShares Balanced ESG ETF and the iShares High Growth ESG ETF, providing investors with important timetable details and tax compliance reminders.

Mayne Pharma’s planned acquisition by Cosette Pharmaceuticals faces a delay as the Foreign Investment Review Board postpones its decision, potentially pushing back key court proceedings.

PainChek Limited has confirmed FDA De Novo classification for its PainChek Adult App, promptly disclosing the material regulatory milestone to the ASX and signalling a significant step towards US market entry.

Structural Monitoring Systems Plc faces a high-stakes legal battle as CEO Ross Love and Turton House Group initiate Federal Court proceedings alleging adverse action and whistleblower victimisation.

Strike Energy Limited has addressed ASX concerns over a delayed filing of a director’s interest notice, attributing the lapse to administrative oversight while affirming confidence in its compliance processes.

Health Canada has requested additional information, extending its review of CLINUVEL’s SCENESSE® for erythropoietic protoporphyria (EPP) into 2026. Meanwhile, Canadian patients continue to access the treatment via a Special Access Program.

Aspen Group has upgraded its FY26 pre-tax earnings guidance by 6%, driven by strong rental income growth and development profits amid Australia's acute housing shortage. The company also announces a strategic acquisition of a new Sydney headquarters.

Ark Mines has secured Environmental Authority approval for its Sandy Mitchell Rare Earths project in Queensland, marking a crucial step towards obtaining its Mining Licence. The company has also completed a major drilling program, setting the stage for an upcoming Pre-Feasibility Study.

PolyNovo Limited has appointed Bruce Peatey as its new CEO, bringing extensive international healthcare experience to drive the company’s next growth phase. Peatey’s leadership is expected to accelerate PolyNovo’s expansion into new markets and outpatient care.

Santana Minerals has taken a major step forward by acquiring freehold ownership of critical lands and extinguishing royalties at its Bendigo-Ophir Gold Project, enhancing project economics amid a strong gold market.

Liberty Metals has secured an option to acquire three strategically located critical mineral projects in Brazil, targeting high-purity rutile and rare earth elements. This move positions the company in a Tier 1 mining jurisdiction with promising exploration upside.

Firebrick Pharma has secured a $102,000 investment from its Philippines strategic partner, Pharma Nutria N.A., Inc., reinforcing its position ahead of the Nasodine nasal spray launch in 2026.